Update information
Minor changes since publication
February 2014: Implementation section updated to clarify that dronedarone is recommended as an option for treating non-permanent atrial fibrillation.
December 2012: Recommendation 1.1 amended to reflect the change in the dronedarone marketing authorisation.
October 2012: A note has been added explaining the review decision for this guidance and the change in the dronedarone marketing authorisation.
ISBN: 978-1-4731-6125-403